Get Quote

Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Game Rating: 1 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Recs

0
Member Avatar LexTNZorro (78.52) Submitted: 10/01/2010 10:36:37 : Outperform Start Price: $2.90 KERX Score: +132.18

http://seekingalpha.com/article/181734-keryx-biopharma-a-well-capitalized-comeback-story-with-multiple-catalysts?source=feed

Report this Post Reply

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.